Nature Methods 3, 361 - 368 (2006)
Published online: 20 April 2006; | doi:10.1038/nmeth872
Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profilingPeter O Krutzik
& Garry P Nolan
Department of Microbiology and Immunology, Baxter Laboratory in Genetic Pharmacology, Stanford University, Stanford, California 94305, USA.
Correspondence should be addressed to Garry P Nolan gnolan@stanford.edu Flow cytometry allows high-content, multiparameter analysis of single cells, making it a promising tool for drug discovery and profiling of intracellular signaling. To add high-throughput capacity to flow cytometry, we developed a cell-based multiplexing technique called fluorescent cell barcoding (FCB). In FCB, each sample is labeled with a different signature, or barcode, of fluorescence intensity and emission wavelengths, and mixed with other samples before antibody staining and analysis by flow cytometry. Using three FCB fluorophores, we were able to barcode and combine entire 96-well plates, reducing antibody consumption 100-fold and acquisition time to 5–15 min per plate. Using FCB and phospho-specific flow cytometry, we screened a small-molecule library for inhibitors of T cell–receptor and cytokine signaling, simultaneously determining compound efficacy and selectivity. We also analyzed IFN- signaling in multiple cell types from primary mouse splenocytes, revealing differences in sensitivity and kinetics between B cells, CD4+ and CD4- T cells and CD11b-hi cells.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
